Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bone strength and surrogate markers: the first, second, and third fiddle.

× No keyword cloud information.

5 in total

1. BMD change predicts bone fracture risk due to zoledronate treatment.

Authors:
Journal: Bonekey Rep Date: 2012-09-19

2. Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE Project.

Authors: Richard Eastell; Eric Vittinghoff; Li-Yung Lui; Charles E McCulloch; Imre Pavo; Arkadi Chines; Sundeep Khosla; Jane A Cauley; Bruce Mitlak; Douglas C Bauer; Mary Bouxsein; Dennis M Black
Journal: J Bone Miner Res Date: 2021-09-24 Impact factor: 6.390

Review 3. Bisphosphonates and bone quality.

Authors: Michael Pazianas; Stefan van der Geest; Paul Miller
Journal: Bonekey Rep Date: 2014-05-07

4. Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.

Authors: P D Miller; R R Recker; S Harris; S Silverman; D Felsenberg; J Reginster; B-M Day; C Barr; D Masanauskaite
Journal: Osteoporos Int Date: 2013-10-18 Impact factor: 4.507

Review 5. PINP as a biological response marker during teriparatide treatment for osteoporosis.

Authors: J H Krege; N E Lane; J M Harris; P D Miller
Journal: Osteoporos Int Date: 2014-03-06 Impact factor: 4.507

5 in total